Room For Improvement In Balancing Epileptic Seizure Control And Side Effects
On the heels of the nation's largest event dedicated to the epilepsy community, the National Walk for Epilepsy, advocates have announced their recommendations in response to a new national survey uncovering key challenges facing the epilepsy community.
Study May Lead To Improved Treatments For Epilepsy
Using a rodent model of epilepsy, researchers found one of the body's own neurotransmitters released during seizures, glutamate, turns on a signaling pathway in the brain that increases production of a protein that could reduce medication entry into the brain.
Elderly Epilepsy Patients Have Higher Risk Of Cognitive Decline
An article published in the May 2008 issue of Epilepsia calls attention to the lack of knowledge regarding cognitive aging in chronic epilepsy patients. For persons with chronic epilepsy, little is known about the impact of aging on the course of cognitive and brain health, the prevalence of clinical disorders of aging (mild cognitive impairment, dementia), or the disease burdens and risk factors associated with abnormal cognitive and brain aging.
Genetic Cause For A Type Of Childhood Epilepsy Identified By UCLA VA Scientists
Imagine "blanking out" of consciousness up to 200 times daily while you're learning in a classroom, playing baseball, taking ballet lessons or riding a bike. This is a common occurrence in the life of a child with childhood absence epilepsy (CAE). The condition is associated with frequent "absent" seizures where the patient's consciousness is impaired leaving the child staring blankly ahead not aware or responsive for up to 10 seconds at a time.
First EMEA Licensed Treatment Specifically For LGS Offers New Hope For Patients With Epilepsy
Eisai Europe Limited, (Headquarters: London, Chairman and CEO Yutaka Tsuchiya) today announced publication of the results of a major study of its new anti-epileptic agent Inovelon (rufinamide) indicated for adjunctive therapy in Lennox-Gastaut Syndrome (LGS), a severe form of generalised epilepsy that develops in early childhood.
Gene Mutation In Rare Form Of Epilepsy
Scientists have identified a genetic mutation responsible for a rare condition called epilepsy and mental retardation limited to females (EFMR), The Times reports. As the name suggests, this condition only affects females and causes seizures that start in infancy or early childhood, as well as cognitive impairment.
Diabetes Drug May Hold Potential As Treatment For Epilepsy, Using Same Mechanism As Ketogenic Diet
Two years ago, University of Wisconsin-Madison scientists reported they had suppressed epileptic seizures in rats by giving them a glycolytic-inhibitor, inhibiting the brain's ability to turn sugar into excess energy and blocking the expression of seizure-related genes.
Randomised Trial Confirms Efficacy Of Ketogenic Diet In Preventing Epileptic Seizures In Children
A randomised controlled trial has confirmed the efficacy of the ketogenic diet in helping control and prevent epileptic seizures in children with drug-resistant epilepsy. These are the conclusions of authors of an Article published early Online and in the June edition of The Lancet Neurology.
Mutant Gene Causes Epilepsy, Intellectual Disability In Women
A mutated gene has been discovered as the key behind epilepsy and mental retardation specific to women, thanks to new research at Adelaide's Women's & Children's Hospital and the University of Adelaide, Australia.The world-first discovery, published in Nature Genetics, shows that although men carry the 'bad' gene, only women are affected.
Data Show Rufinamide, An Investigational Adjunctive Treatment For Lennox- Gastaut Syndrome, Reduced Drop Attacks By More Than 40
Eisai Corporation of North America announced the publication of a placebo-controlled study in Neurology that found patients with Lennox-Gastaut syndrome (LGS) treated with the investigational antiepileptic agent rufinamide as adjunctive therapy experienced more than 40% fewer drop attacks than patients who received placebo (increase of 1.